Roundup and analysis of the top headlines on health security, pandemic preparedness, COVID-19, and other news from the Johns Hopkins Center for Health Security


Please note that some links may require subscription or registration.

February 22, 2024



TOP NEWS

Disagreement continues over pathogen access and benefit-sharing system, intellectual property waivers at pandemic accord negotiations


A little more than 2 weeks remain for negotiation of a WHO instrument on pandemic prevention, preparedness, and response, but disagreement among member states remains over several clauses. One major challenge involves access to and sharing of pathogens, known as pathogen access and benefit-sharing (PABS). This pertains to how countries should exchange information about potential pandemic pathogens, as well as whether or how entities that share genomic sequencing data and biological material of such pathogens are rewarded. A PABS system would not only help countries share pathogens and genetic sequence data but also better ensure equitable access to pandemic-related products and other benefits. Both the European Union and the US have disagreed with African nations over a PABS mechanism, which is addressed in Article 12 of the draft agreement.


On February 19, Dr. Alexandra Phelan, Senior Scholar at the Johns Hopkins Center for Health Security and Associate Professor at the Johns Hopkins Bloomberg School of Public Health, delivered a speech at the WHO Intergovernmental Negotiating Body meeting for its eighth session to negotiate a pandemic accord, stating that “the current governance regime for samples without a specialized international instrument is bilateral and transactional, untenable for both equity and science.” Dr. Phelan continued, “PABS is the answer: a multilateral system that for countries both embeds and decouples access from benefits, enshrining mutual obligations that rebuild trust in international law and the international system, and realize the right to health.” Read the Center’s news story.


Discussion over intellectual property waivers represents an additional sticking point for negotiations. This week, a bipartisan group of US lawmakers wrote to National Security Advisor Jake Sullivan, noting their opposition to any weakening of intellectual property protections for the makers of vaccines, therapeutics, and diagnostic tests in a pandemic accord.


Various recent studies examine prevalence, possible causes of long COVID


Multiple studies published in the last week examine several aspects of long COVID, including its prevalence in the US, potential causes of the condition’s symptoms, and promising treatments.


Long COVID prevalence in the US varies by state and territory, with prevalence exceeding 8.8% in 7 states, according to a study published last week in the US CDC’s Morbidity and Mortality Weekly Report. The US Virgin Islands ranked lowest at 1.9% prevalence, and West Virginia ranked highest at 10.6%. Nationally, 6.4% of US adults reported ever having experienced long COVID. The study used information taken from the 2022 Behavioral Risk Factor Surveillance System (BRFSS), a population-based cross-sectional survey.


A recent study published in the Annals of Epidemiology found that the prevalence of long COVID symptoms at 30- and 90-days post-infection were 43% to 58% lower among adults who were fully vaccinated before SARS-CoV-2 infection. The study, which involved data from 4,605 participants in the Michigan COVID-19 Recovery Surveillance Study, found that overall, 32.2% of adults with confirmed COVID-19 reported long COVID symptoms at 30 days and 17.5% reported symptoms at 90 days.


According to a study published this week in Science Advances, high levels of a specific antiviral protein could be a potential mechanism underlying long COVID, a finding that could help the search to find tests and treatments for the condition. Production of the protein typically stops once acute infection ends, but researchers found that participants with ongoing symptoms had high levels of interferon gamma, or IFN-γ, for up to 31 months after initial infection, suggesting a potential cause for long COVID.


Persistent systemic inflammation and sustained dysfunction in the blood-brain barrier (BBB) are potential causes of long COVID-associated brain fog, according to research published this week in Nature Neuroscience. MRI scans showed signs of a leaky BBB in long COVID patients who self-reported symptoms of brain fog but not in those who did not report the symptom nor in those who recovered fully from COVID-19.


Another study published in Scientific Reports found that long COVID patients who received hyperbaric oxygen therapy reported sleeping better, having less pain and more energy, and dealing with fewer emotional and physical issues a year later. More research is needed to confirm the findings, as the latest study did not include a control group.

MORE HEADLINES

WHO director general warns world unprepared for next pandemic in interview, speech

CNN: W.H.O. says we are not prepared for next pandemic in exclusive interview with CNN

Fox News: WHO chief's dire warning: Disease X outbreak 'a matter of when, not if'


Center for Health Security Senior Scholar Dr. Amesh Adalja discusses the concept of “Disease X” and how it is helping drive pandemic preparedness efforts in this interview with the Johns Hopkins Bloomberg School of Public Health.


Novavax could pay Gavi up to $475M to settle dispute over canceled COVID vaccine purchase agreement

STAT: Novavax and Gavi end a bitter dispute over Covid-19 vaccines with a refund up to $400 million

CNBC: Novavax to settle dispute over canceled Covid vaccine purchase agreement


Articles discuss various issues involving US, Chinese biotechnology, virology research

AP: US rivalry with China expands to biotech. Lawmakers see a failure to compete and want to act

The Telegraph: China is experimenting on mutant Covid strains again – should we be worried?

Science: Lawmaker raises new flap over U.S.-funded virology research that critics call risky


New international group aims to strengthen biosecurity, biosafety

Science: New biosecurity group aims to prevent biotech disasters

Devex: New firm to fight biosecurity threats

NTI: New International Biosecurity Organization Launched to Safeguard Bioscience

The Telegraph: DNA bought online could be used to create dangerous pathogens, experts warn

See also: RAND: Emerging Technology and Risk Analysis: Synthetic Pandemics


Influenza-like illness activity remains high in more than half of US

Force of Infection: Outbreak Outlook - National - February 19

ABC News: 25 states see 'high,' or 'very high' levels of respiratory illness activity: CDC

CIDRAP: Flu continues to rise in some US regions as COVID markers decline

CIDRAP: Flu remains elevated in the Northern Hemisphere


Reported changes to US CDC COVID-19 isolation rules likely would align with other respiratory disease guidance, but some medically vulnerable people express concern

Washington Post: High-risk patients alarmed by CDC’s plan to ease covid isolation guidance

Your Local Epidemiologist: Changing Covid-19 isolation?

See also: NBC News: CDC may recommend a spring Covid booster for some groups


The guidance would bring COVID-19 into line with how other common respiratory viruses are managed: with isolation recommended until the individual has mild and improving symptoms and is fever-free (without pharmaceutical aid) for 24 hours. … I welcome the proposed guidance change because it reflects the progress that has been made in the management of COVID-19. When evaluating this guidance, it is critical to understand that SARS-CoV-2, the cause of COVID-19, is situated among the myriad respiratory viruses that infect humans. – Dr. Amesh Adalja, Senior Scholar at the Center for Health Security, writing in a MedPage Today commentary


Multicountry analysis of more than 99 million individuals vaccinated against COVID-19 confirms shots linked to increased risks for certain adverse event, including myocarditis, Guillain-Barré syndrome

The Hill: Largest multicountry COVID study links vaccines to potential adverse effects

Fox News: Largest-ever COVID vaccine study links shot to small increase in heart and brain conditions


Tensions high at recent US House subcommittee hearing on vaccine safety, adverse events reporting system

The Hill: Tensions run high in House hearing on COVID vaccine safety, efficacy

STAT: Covid-19 vaccine confidence soured by officials’ messaging, Republicans argue

MedPage Today: Lawmakers Clash Over COVID Vaccine Safety at House Hearing

Politico: Revisiting vaccine safety


US congressman threatens to subpoena HHS officials as part of investigations into COVID-19 origins, federal pandemic response

STAT: Key congressman blasts HHS for lack of cooperation on Covid-19

The Hill: House COVID panel leader threatens to subpoena HHS for lack of cooperation


Paxlovid use associated with lower risk of hospitalization; potential for viral rebound should not deter treatment’s use, experts say

CIDRAP: Paxlovid use tied to 84% lower risk of hospital care

Johns Hopkins Bloomberg School of Public Health: COVID Rebound Can Happen Whether or Not You Take Paxlovid

Medscape: What to Know About COVID Rebound (commentary)


Renters facing eviction had significantly increased risk of death over first 2 years of COVID-19 pandemic, study shows

CIDRAP: Those getting eviction notices during COVID pandemic at greater risk for death, study finds

CNN: Mortality surged for renters facing eviction during the pandemic, study finds


Findings of NIH study of ME/CFS, chronic fatigue may have implications for long COVID patients

New York Times: Study of Patients With a Chronic Fatigue Condition May Offer Clues to Long Covid

STAT: NIH study of ME/CFS points to immune dysfunction and brain abnormalities at core of long-dismissed disease

Science: Sweeping chronic fatigue study brings clues but not clarity to mysterious syndrome

NPR: An ambitious NIH study has brought new attention to chronic fatigue syndrome


More than half the world at high or very high risk of measles outbreaks, WHO says

Reuters: More than half the world faces high measles risk, WHO says

NBC News: Measles infections pose far more risks than most realize

ABC News: Amid rising measles cases, a new generation of doctors is being taught how to spot the disease


Measles now in all regions of England; European health authorities urge greater vaccination coverage

The Guardian: Measles in all English regions, says UKHSA, as it urges parents to get children jabbed

European CDC: High vaccination coverage key against expected increase of measles cases in the EU/EEA

WHO Europe: Rapid measles outbreak response critical to protect millions of vulnerable children

The Guardian: ‘It is shameful’: why the return of Victorian-era diseases to the UK alarms health experts


Florida measles outbreak associated with elementary school grows to 6 cases

USA Today: Measles outbreak in Florida grows: What to know about virus flare-ups across the US

NBC News: Six cases of measles confirmed in outbreak at a Florida elementary school

CIDRAP: Florida's school measles cluster grows; Ohio and Washington report cases


US government describes actions around domestic, international mpox response; mpox symptoms evolved to be more diverse, study suggests

US Administration for Strategic Preparedness & Response: ASPR Prepares for Changing Landscape of Mpox Response at Home and Abroad

CIDRAP: Mpox symptoms evolved over the past 5 decades, meta-analysis finds

See also: CBS Philadelphia: 8 students at Richmond School potentially exposed to mpox in Philadelphia: school district


WHO reports 4 cases of MERS-CoV in Saudi Arabia over past 6 months; study describes seasonal peaks of disease in camels, serologic detection in humans

News Medical: Study reveals seasonal MERS-CoV peaks in Kenyan camels and potential human transmission

WHO: Middle East Respiratory Syndrome Coronavirus - Kingdom of Saudi Arabia

CIDRAP: WHO reports 4 more MERS cases from Saudi Arabia


11 nations in PAHO region reporting increasing dengue activity; Brazil among hardest hit

CIDRAP: Dengue activity in the Americas already outpacing last year's surge

AP: Brazil’s health agents scour junkyards and roofs for mosquitos to fight dengue epidemic

PAHO: PAHO calls for strengthened measures against Aedes aegypti mosquitoes to combat dengue

Forbes: Dengue Rages Around The Globe. Where Are The Vaccines? (opinion)


Climate change, poor sewage systems, unchecked border crossings driving Southern Africa cholera outbreaks; WHO publishes safe drinking water guidelines for small operators

Al Jazeera: What’s fueling the deadly cholera outbreak in Southern Africa?

Health Policy Watch: As Cholera Surges, WHO Publishes Safe Drinking Water Guidelines for Small Operators – First in Nearly 30 Years


African nations can reverse lagging progress against malaria with greater investments, global efforts to mitigate climate change, report says

African Leaders Malaria Alliance: Africa faces a perfect storm in the fight against malaria

The Telegraph: Conflict and climate change are supercharging malaria, but it can be stopped (opinion)


Bloomberg News investigation examines bed net manufacturing changes, impact on malaria prevention

Bloomberg: The World Can’t Abandon the Fight Against Malaria (editorial)

Bloomberg: Big Take: The Business Call Behind a Malaria Rebound

Bloomberg: One Business Decision Made the World’s Losing Battle With Malaria Even Tougher

Bloomberg: Papua New Guinea Was Headed Towards a Malaria-Free Future. Until It Wasn’t.


CEPI funds 4-year project to develop reliable rapid tests for Nipah, Lassa virus infections

The Telegraph: Scientists race to develop rapid testing for two of the world’s deadliest pathogens

CEPI: Testing the tests: Scientists seek out best on-the-spot diagnostics for deadly Nipah and Lassa


Crop-destroying pests could impact more areas as climate warms, becomes wetter

New York Times: Locust Swarms Could Expand Their Range in a Hotter, Stormier World

Devex: Climate change-driven pests silently devastate Indian farms


US CDC investigating multiple foodborne illness outbreaks of E. coli, Salmonella

NPR: The CDC investigates a multistate E. coli outbreak linked to raw cheddar cheese

CIDRAP: CDC announces E coli outbreak tied to raw milk cheese, more charcuterie Salmonella cases

Editor: Alyson Browett, MPH

Contributing Editor: Prarthana Vasudevan, MS, MSPH, DrPH (c)

Give Today
Click to Subscribe
 
Twitter  Youtube  Linkedin